baber/WOPTO huggingface dataset:
Patent NZ-548887-A (NZ)
Title: Lottery ticket dispensing machine for multiple priced tickets based on variable ratios
Inventor: WRIGHT ROBERT J
IPC: A63F13/00
Filed: 2004-06-28
Abstract: A multi-priced lottery ticket dispensing machine comprises: a price category reception module, a user input module, a lottery ticket printer, and a controller. The price category reception module receives a first price category of a first distribution and a second price category of a second distribution. The second distribution is established so that a first association between the first distribution and the first price category has a variable ratio with a second association between the second distribution and the second price category. The user input module receives an input from a user indicating one of a plurality of price categories in which a lottery ticket is to be purchased. One of the plurality of price categories is the first price category and another one of the plurality of price categories is the second price category. The lottery ticket printer prints a lottery ticket from the price category chosen by the user input device and the controller receives the first price category from the price category reception module. The controller receives the second price category from the price category reception module and the controller receives the input from the user. The controller provides an instruction to the lottery ticket printer to print the lottery ticket according to the input.
Patent NZ-550087-A (NZ)
Title: Imidazole compounds
Inventor: BUZARD DANIEL J
IPC: A61K31/4545
Filed: 2005-03-24
Abstract: Disclosed are an imidazole compound of formula (I) or (II), and a pharmaceutical composition comprising the imidazole compounds for treating or preventing inflammatory and H4 receptor-mediated conditions, and inhibiting leukocyte recruitment.
Patent NZ-552907-A (NZ)
Title: Method of up-regulating tumor antigen expression using thymalfasin
Inventor: RASI GUIDO
Filed: 2003-06-30
Abstract: Disclosed are methods for up-regulating tumor cell antigen expression on colorectal cancer cell using thymalfasin. This enhanced ELP expression makes possible a variety of improved diagnostic and therapeutic methods based on improved cancer cell targeting. In particular, disclosed is the use of an effective amount of thymalfasin in a medicament that is adapted to administer the thymalfasin at a dose between 2 micrograms/kg body weight and 6 milligrams/kg body weight, for improved cancer cell targeting.
Patent NZ-554936-A (NZ)
Title: Tricyclic Guanidine Derivatives As Sodium-Proton Exchange Inhibitors
Inventor: LAL BANSI
IPC: A61K31/382
Filed: 2005-11-08
Abstract: Disclosed is a tricyclic guanidine derivative of formula 1 wherein U is C(O), CRaRb, O, NRa, or S(O)m; V is CRaRb or NRa; W is S(O)m; wherein at least one or R1-8 is guanidine or guanidine carbonyl and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of the above derivative for the manufacture of a medicament for the treatment of ischemic conditions associated with abnormal sodium-proton exchange activity in a mammal. Also disclosed is a process of making a compound of formula 1 where guanidine is reacted with the tricyclic base structure.
Patent NZ-555491-A (NZ)
Title: Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
Inventor: CAMPIANI GIUSEPPE
IPC: C07D487/04
Filed: 2006-01-02
Abstract: Disclosed is an aryl piperazine derivative represented by Formula (I) an enantiomer thereof or a mixture of its enantiomers, or a pharmaceutically acceptable salt thereof, wherein the substituents are described in the specification. Also disclosed is the use of formula I for the manufacture of a pharmaceutical composition for the treatment, prevention or alleviation of a disease or a disorder or a condition of a mammal, including a human, which disease, disorder or condition is responsive to modulation of the dopamine and serotonin receptors.
Patent NZ-562224-A (NZ)
Title: Synergistic fungicidal active substance combinations comprising carboxamide derivatives with tolclofos-methyl and / or flutolanil
Inventor: SUTY-HEINZE ANNE
IPC: A01N37/22
Filed: 2006-03-27
Abstract: Disclosed are synergistic fungicidal active compound combinations which comprise a carboxamide of the general formula (1) in which R1 represents hydrogen, halogen, alkyl or haloalkyl having 1 to 7 fluorine, chorine and/or bromine atoms, and where A is a substituted phenyl or heterocyclic moiety as defined herein; and at least one compound selected from tolclofos-methyl or flutolanil. Also disclosed is a method for controlling unwanted phytopathogenic fungi, characterised in that the above active compound combinations are applied to the unwanted phytopathogenic fungi and/or their habitat and/or seed.
Patent NZ-562495-A (NZ)
Title: Sustained-release tablet comprising pramipexole
Inventor: NOACK RAINER
IPC: A61K31/513
Filed: 2003-07-25
Abstract: A method for determining suitability of a starch for use in a sustained-release orally deliverable tablet comprising an active pharmaceutical agent, having solubility not less than about 10 mg/ml is disclosed, wherein the method comprises the steps of: (a) preparing compacts of a sample of the starch on an automated tablet press at a range of compression forces applied for a dwell time of at least about 4 seconds; (b) measuring hardness of each compact, expressed as the force required to cause crushing of the compact; (c) determining solid fraction of each compact; (d) calculating tensile strength of each compact from the equation given in the specification; (e) establishing relationship of tensile strength to solid fraction of the compacts; and (f) using said relationship to estimate tensile strength at a solid fraction representative of a desired sustained-release tablet; the starch being deemed suitable for said use if its tensile strength as so estimated is at least about 0.15 kN cm-2. Also disclosed is a process for preparing a sustained-release pharmaceutical composition in a form of an orally deliverable tablet comprising an active pharmaceutical agent which is pramipexole or a salt thereof, the process comprising selecting by a suitable test a starch having a tensile strength of at least about 0.15 kN cm-2 at a solid fraction representative of the tablet; admixing with the selected starch a hydrophilic polymer and pramipexole or a salt thereof to provide a mixture wherein the agent is dispersed in a matrix comprising the polymer and the starch; and compressing the mixture to form said tablet.
Patent NZ-563866-A (NZ)
Title: Thiazole compounds and methods of use
Inventor: ZHANG SUOMING
IPC: A61K31/426
Filed: 2006-05-09
Abstract: The disclosure relates to thiazole compounds of the formula shown herein, and the pharmaceutically acceptable salts and hydrates thereof, wherein the variables Ar1 R2, R3, R4, and r are as defined in the specification. These thiazole compounds possess potent antiviral activity and are potent and/ or selective inhibitors of Hepatitis C virus replication. Certain compounds described herein inhibit assembly of the HCV replication complex. These thiazole compounds are suitable for treating patients suffering from certain infectious diseases including viral infections, particularly HCV infections in human patients as well as other animals, including livestock and domesticated companion animals.
Patent NZ-569063-A (NZ)
Title: Animal model for perimenopause and menopause and methods of inducing ovarian failure
Inventor: HOYER PATRICIA B
IPC: G01N33/50
Filed: 2003-08-29
Abstract: Provided is a mammalian non-human female animal having at least a partial depletion of ovarian primordial follicles and at least one characteristic of perimenopause and/or menopause induced by administration of at least one compound selected from the group consisting of4-vinylcyclohexene-l, 2-epoxide and 4-vinylcyclohexene-7, 8-epoxide. Also provided are a method of preparing such animals and a method of screening agents affecting ovarian primordial follicles and characteristics of perimenopause and/or menopause.
Patent NZ-569771-A (NZ)
Title: Pyrimidine derivatives used as PI-3 kinase inhibitors
Inventor: BURGER MATTHEW
IPC: A61K31/506
Filed: 2007-01-22
Abstract: Disclosed is a pyridine or pyrimidine substituted 2-morpholin-4-pyrimidinyl amine of formula (I) or (III) where the variables are as disclosed in the description. Also disclosed is a composition comprising a compound of formula (I) or (III) and the use of a compound of formula (I) or (III) in the manufacture of a medicament for the treatment of cancer, in particular for inhibiting P13-K activity.
Patent NZ-571089-A (NZ)
Title: Safety bow for a children's chair that connects to the backrest and set in a detachable manner
Inventor: OPSVIK PETER
IPC: A47D15/00
Filed: 2007-02-23
Abstract: A safety bow (40) for use in children's chair (1) is disclosed. The chair comprising a seat plate (2), a backrest (3, 4) and possibly two side pieces (5). The backrest or side pieces have at least one opening each, the safety bow being a three armed constructional part in one piece. The safety bow has two first ends (43 Fig 3) with first and second connecting members (44 Fig 3) for hooking into the opening(s) in the backrest (3, 4) or the side pieces (5) and a third end comprising a third connecting member (46) for detachable fixing to the seat plate (2).
Patent NZ-572250-A (NZ)
Title: Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
Inventor: RAY NICHOLAS CHARLES
IPC: A61K31/519
Filed: 2007-05-03
Abstract: Disclosed are tetrahydropyrrolopyrimidinediones represented by general formula (I). Also disclosed are multimeric compounds comprising molecules of formula (I) covalently linked through a linker. Also disclosed is the use of the compounds of formula (I) for treating a disease or condition in which HNE is implicated such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, lung fibrosis, pneumonia, acute respiratory distress syndrome (ARDS), pulmonary emphysema, smoking induced emphysema or cystic fibrosis, asthma, rhinitis, psoriasis, dermatitis, (atopic and non-atopic), Crohn's disease, ulcerative colitis, or irritable bowel disease.
Patent NZ-578661-A (NZ)
Title: Tricyclic compounds and their use as glucocorticoid receptor modulators
Inventor: CHENG HENGMIAO
IPC: A61K31/44
Filed: 2008-01-28
Abstract: Disclosed is a tricyclic compound of Formula (I) or salt thereof. Also disclosed is the use of a compound of Formula I or salt thereof in the manufacture of a medicament for treating a condition mediated by glucocorticoid receptor activity such as rheumatoid arthritis, dermatitis, asthma, Alzheimer's disease and inflammatory bowel disease.
Patent NZ-581940-A (NZ)
Title: Conserved neisserial antigens
Inventor: RAPPUOLI RINO
IPC: C12N15/09
Filed: 2000-04-28
Abstract: Provided is an isolated or recombinant protein consisting of a fragment of Neisseria ORF287 protein, wherein said fragment is 7 or more amino acids in length and has a sequence that is conserved in at least 50% of Neisseria in a Neisseria reference population, comprising at least one N. gonorrhoeae strain and at least three N. meningitidis strains selected from a specified list and N. meningitides strain c11, subject to the proviso that at least one N. meningitidis strain is from each of serogroups A, B and C, and wherein said protein is not a full-length ORF287 protein of N. meningitidis strain MCS8 having the amino acid sequence: MFKRSVIAMACWALSACGGGGGGSPDVKSADTLSKPAAPVVSEKETEAKEDA PQAGSQGQGAPSAQGSQDMAAVSEENTGNGGAVTADNPKNEDEVAQNDMPQ NAAGTDSSTPNHTPDPNMLAGNMENQATDAGESSQPANQPDMANAADGMQ GDDPSAGGQNAGNTAAQGANQAGNNQAAGSSDPIPASNPAPANGGSNFGRVD LANGVLIDGPSQNITLTHCKGDSCSGNNFLDEEVQLKSEFEKLSDADKISNYKK DGKNDKFVGLVADSVQMKGINQYIIFYKPKPTSFARFRRSARSRRSLPAEMPLI PVNQADTLIVDGEAVSLTGHSGNWAPEGNYRYLTYGAEKLPGGSYALRVQGE PAKGEMLAGAAVYNGEVLHFHTENGRPYPTRGRFAAKVDFGSKSVDGIIDSGD.
Patent NZ-582311-A (NZ)
Title: Finned ring LED lamp with optical lenses
Inventor: VIGLIONE MASSIMO
IPC: F21S8/00
Filed: 2009-12-23
Abstract: Disclosed is an LED lighting device(10) for outdoors and large covered areas comprising a plurality of LED light sources constrained to a lamp body. The lamp body (13) has a ring base from which a plurality of fins projects upwards, and at least one substantially flat optical element (12) being constrained at the bottom to the finned ring lamp body. The group made of the lamp body and the optical element form a toroid (12, 13). The finned ring lamp body and the at least one optical element define a first chamber inside the toroid for housing the LED light sources and circuitry for managing the plurality of LED light sources. The plurality of LED light sources and the circuitry are directly constrained to the ring base of the lamp body.
Patent NZ-585438-A (NZ)
Title: Novel crystalline forms of 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-pyrimidin-4-yI]-benzenesulfonamide
Inventor: GAITONDE ABHAY
IPC: A61K31/506
Filed: 2008-10-24
Abstract: Disclosed are crystalline forms of bosentan (4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-pyrimidin-4-yI]-benzenesulfonamide), characterized by an X-ray diffraction pattern comprising peaks at 4.02, 6.12, 8.38, 9.39,10.04,15.26,17.72, 17.98, 18.81, 19.28,20.31,21.05,27.57,31.91 and 45.65 plus or minus 0.2 degrees theta. The crystalline form of bosentan is useful for treating or preventing an endothelien receptor mediated disorder such as cardiovascular disorders. Specific cardiovascular disorders treated include hypertension, pulmonary hypertension, ischemia, vasospasm or angina pectoris.
Patent NZ-588998-A (NZ)
Title: Applying power masks with configurable power ramps to subframes and OFDM symbols
Inventor: KAZMI MUHAMMAD
IPC: H03G3/30
Filed: 2008-12-18
Abstract: 588998 Disclosed is a method for transmission output power control in a transmitter for use in cellular telecommunications. The method includes setting a pre-defined power mask for at least one of a sub frame and an Orthogonal Frequency-Division Multiplexing, OFDM, symbol of a signal transmission. The power mask is defined by at least one parameter associated with any of the following: a starting point of a first power ramp; an ending point of the first power ramp; a starting point of a second power ramp; and an ending point of the second power ramp. The method also includes adapting at least one of the at least one power mask parameter of the power mask to a signal transmission characteristic of the signal transmission such that, depending upon the signal transmission characteristics, the first and/or second power ramps may be placed either inside or outside the subframe or OFDM symbol. The transmission characteristics comprise the content of the signal to be transmitted in the subframe or OFDM symbol and/or the content of the signal to be transmitted in a successive subframe or OFDM symbol. The method further includes applying the adapted power mask to at least one of the sub-frame and the OFDM symbol.
Patent NZ-590491-A (NZ)
Title: Process for delignifying and bleaching chemical pulp using molybdate from molybdenum or tungstate
Inventor: DIETZ THOMAS DR
IPC: D21H23/00
Filed: 2011-01-14
Abstract: Disclosed herein is a process for delignifying and bleaching chemical pulp, comprising a bleaching stage in which a) in a first step, chemical pulp is reacted in an aqueous mixture containing 3 to 30% by weight of chemical pulp with chlorine dioxide in an amount corresponding to a Kappa factor in the range from 0.02 to 0.25 at a temperature of 50 to 150°C and a pH in the range from 2 to 7 until more than 90% of the chlorine dioxide has reacted and b) the mixture obtained in the first step is further reacted, without separating off constituents of the mixture, in a second step with 0.1 to 5% by weight of hydrogen peroxide in the presence of a molybdate in an amount of 10 to 2000 ppm of molybdenum or of a tungstate in an amount of 200 to 10 000 ppm of tungsten at a temperature of 50 to 150°C, the amounts being based in each case on the mass of dry chemical pulp used.
Patent NZ-590745-A (NZ)
Title: Apparatus and method for ply bonding as well as multi-ply product using embossed rollers without glue
Inventor: SAUTER JURGEN
IPC: B31F1/07
Filed: 2008-08-07
Abstract: Apparatus for bonding at least two plies of a fibrous web, comprises a first roller having an outer periphery, with at least one embossing protuberance 61 provided on the outer periphery, and a second roller 63 which has an outer periphery and is elastic in a radial direction. The second roller 63 comprises at least an inner layer and an outer layer that is harder than the inner layer. The second roller 63 together with the first roller forms a nip through which the at least two plies are to be fed. An embossing element 60 is located on top of at least one of the embossing protuberance(s) 61. The embossing area of each embossing element 60 is smaller than the embossing area of the corresponding embossing protuberance(s) 61 so that the at least two plies are bonded at discrete locations corresponding to the embossing elements. The embossing element(s) 60 are smaller in height than the corresponding embossing protuberance(s) 61.
Patent NZ-590938-A (NZ)
Title: Improvements to adjustable supports for access hatch frames
Inventor: GUMBLEY NEIL WATSON
IPC: B63B19/00
Filed: 2011-02-04
Abstract: 590938 An adjustable support for an access hatch frame or manhole frame. The support has an annular lower frame member with at least one upper interface surface and an annular upper frame member with at least one lower interface surface. The support has a number of height adjustable mounting points. The plane defined by the interface of the upper interface surface and the lower interface surface is not parallel to a plane defined by a lower surface of the lower frame member or a upper surface of the upper frame member. The lower interface surface and the upper interface surface are bevelled to aid location and engagement between the upper and lower frame members. Rotation of the upper frame member relative to the lower frame member about the planar interface varies the relative angle between the plane defined by the lower surface of the lower frame member and the plane defined by the upper surface of the upper frame member. A third frame member is mounted to the upper surface of the upper frame member via the height adjustable mount points.
Patent NZ-594750-A (NZ)
Title: An apparatus and method for manufacturing an absorbent body for an absorbent article, such as a diaper or sanitary napkin
Inventor: ISHIKAWA MASAHIKO
IPC: D21J5/00
Filed: 2010-01-27
Abstract: Abstract for 594750 A manufacturing apparatus for manufacturing an absorbing body for an absorptive article, the manufacturing apparatus manufacturing the absorbing body by By passing air (3) containing a liquid absorbent material (2) in the thickness direction of an air-permeable member (50) covering an opening (27a) of a mold member (27), the liquid absorbent material is deposited on the air-permeable member. A reinforcing member (60) is provided that reinforces the air-permeable member by being superimposed on the air-permeable member in the thickness direction. The reinforcing member is a mesh in which a first wire (61) and a second wire (62) intersect and are connected at intersection points (CP60) thereof. At the intersection points, the reinforcing member is joined to the air-permeable member.
Patent NZ-596409-A (NZ)
Title: Anti macrophage migration inhibitory factor antibodies
Inventor: KERSCHBAUMER RANDOLF
IPC: A61K39/395
Filed: 2008-12-30
Abstract: NZ 596409 Disclosed is a monoclonal antibody or an antigen-binding portion thereof that specifically binds to the C-terminal region of macrophage migration inhibitory factor (MIF) and inhibits human MIF biological function, wherein the C-terminal region is the region spanning amino acids 86 to 102 of human MIF. The disclosed antibodies are used in the manufacture of a medicament for treating an immunological disease in a subject.
Patent NZ-598672-A (NZ)
Title: Apparatus for manufacturing molten metal using a furnace with a sloping top
Inventor: TETSUMOTO MASAHIKO
IPC: C21B13/10
Filed: 2010-10-08
Abstract: 598672 An apparatus for manufacturing molten metal, comprising a stationary non-tilting electric furnace including electric heating means 5, where an exhaust gas duct 3 and at least one raw material charging chute 4 are connected to the furnace top. The raw material charging chute 4 is provided in one end of the furnace in the width direction. A secondary combustion burner 6 is provided in the furnace top. The apparatus is configured to manufacture molten metal by first forming a raw material layer 12 by charging a particular amount of a carbonaceous material and/or a metal agglomerate raw material into the furnace from the raw material charging chute 4. The raw material layer 12 has a sloping surface extending downward from the one end of the furnace in the width direction toward an electric heating region heated with the electric heating means 5. A metal agglomerate raw material layer 12a is subsequently formed on the sloping surface of the raw material layer 12 by continuously or intermittently charging the metal agglomerate raw material into the furnace from the raw material charging chute 4. A molten metal layer and a molten slag layer are subsequently formed in the furnace by sequentially melting the metal agglomerate raw material near a lower end portion of the metal agglomerate raw material layer by electric heating with the electric heating means 5 while allowing the metal agglomerate raw material layer 12a to descend along the sloping surface of the raw material layer 12, and concurrently thermally reducing the metal agglomerate raw material layer by radiant heat from secondary combustion by blowing oxygen-containing gas into a space, within the furnace, above the metal agglomerate raw material layer 12a from the secondary combustion burner 6 to burn CO-containing gas generated from the metal agglomerate raw material layer 12a. The furnace top includes a sloping furnace top that generally slopes downward from the one end of the furnace in the width direction to the electric heating region.
Patent NZ-610536-A (NZ)
Title: Fixing of perfume on wet skin
Inventor: BALCKE ISABEL
IPC: A61Q19/10
Filed: 2012-10-23
Abstract: Provided is an aqueous cosmetic or dermatological preparation which is substantially emulsifier-free and comprises one or more lipophilic perfume ingredients, one or more lipophobic perfume ingredients, the weight ratio of the lipophilic perfume ingredients: lipophobic perfume ingredients being from about 0.5: 1 to about 4: 1, and at least about 13 % by weight of microcrystalline wax, based on the total weight of the preparation. The preparation is suitable for application to wet or moist skin and may be useful for providing longer lasting fragrance to the skin despite the application of the preparation to wet or moist skin.
Patent NZ-629335-A (NZ)
Title: Method and apparatus for oral flow therapy
Inventor: HOLLEY LIAM
IPC: A62B9/06
Filed: 2013-04-30
Abstract: An oral interface (50) adapted to provide a sealed engagement with a user’s mouth, the oral interface comprising: a teeth engaging portion (54), the teeth engaging portion adapted to conduct a flow of gas to a rear side of an oral cavity of the user during at least a portion of an expiratory phase of the user’s respiratory cycle to wash out carbon dioxide in the user’s oral and/or nasal cavities; and one or more gas delivery tubes (52) arranged to allow a supply of pressurized gas to be delivered into the user’s oral cavity in use.